NGM

NGM Biopharmaceuticals Stock Price

16.11
0.44 (2.81%)
Upgrade to Real-Time
Regular Market
16.11
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
NGM Biopharmaceuticals Inc NGM NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.44 2.81% 16.11 10:26:13
Close Price Low Price High Price Open Price Previous Close
15.58 16.11 15.69 15.67
Bid Price Ask Price Spread News
16.03 16.12 0.09 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
155 9,933 $ 15.83 $ 157,275 190,040 8.55 - 28.32
Last Trade Time Type Quantity Stock Price Currency
10:26:13 100 $ 16.11 USD

NGM Biopharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 1.11B 68.83M 24.32M $ 103.54M $ -77.30M -0.66 -14.35
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

NGM Biopharmaceuticals News

Date Time Source News Article
9/03/202017:32Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
9/03/202016:19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/31/202017:01Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/29/202007:20GlobeNewswire Inc.NGM Bio Presents Comprehensive Findings from 24-Week Phase 2..
8/25/202018:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/25/202018:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
8/18/202008:00GlobeNewswire Inc.NGM Bio Announces Oral Plenary Presentation of 24-Week Phase..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NGM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week19.2719.36514.9317.29247,263-3.16-16.4%
1 Month17.7219.6014.9317.89203,814-1.61-9.09%
3 Months19.3221.1414.9318.33175,026-3.21-16.61%
6 Months13.2523.9511.7118.32261,3742.8621.58%
1 Year15.9128.328.5517.12277,9990.201.26%
3 Years15.1928.328.5516.85219,3800.926.06%
5 Years15.1928.328.5516.85219,3800.926.06%

NGM Biopharmaceuticals Description

NGM Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics based on scientific understanding of key biological pathways for the treatment of cardio-metabolic, liver, oncologic and ophthalmic diseases. The company's products include NGM282 (aldafermin), NGM313 (MK-3655), NGM120, NGM120, NGM621, and NGM395, all these are focused on NASH, diabetes, oncology, AMD and metabolic disease.
Your Recent History
NASDAQ
NGM
NGM Biopha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200925 14:42:26